ArticleFrontiers in public health2026
Can a bigger budget shrink the bill at the bedside? Public health financing as a route to lower out-of-pocket spending in India.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Out-of-pocket payments still finance approximately two-fifths of India's health spending and push an estimated 55 million people into poverty each year. However, the past decade tells a more hopeful story: as the government's share of total health expenditure rose from 28.6 to 48%, the out-of-pocket share fell from 64.2 to 39.4%. This Perspective argues that the most dependable lever India holds against household health costs is its own budget, and that the country's own experience, rather than theory, makes the case. It sets out why public financing lowers out-of-pocket spending through free provision, pooled prepayment, and the state's power as a price-setting purchaser, and why government health expenditure, at approximately 1.9% of gross domestic product, falls short of the 2.5% target India set for itself. The article identifies the largest and most neglected burden in outpatient care and medicines, which absorb approximately two-thirds of out-of-pocket spending yet lie outside the flagship hospitalization scheme, and points to a proven domestic remedy in Tamil Nadu's pooled free-medicines model. Reaching 2.5% of GDP is necessary but not sufficient; how the money is spent, and how cleanly it is purchased, determines how much reaches families.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.